Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

qatar pharma, qatar - dextrose - intravenous infusion - 25 %

Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

qatar pharma, qatar - dextrose - intravenous infusion - 25 %

Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

qatar pharma, qatar - dextrose - solution for infusion - 25 %

Emiriah Arab Bersatu - Inggeris - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmalink store united arab emirates - 500 ml polypropylene bottle - injection - 25% w/v - nutrition , blood-fluids , electrolytes

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous; bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous - solution for injection - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: sodium chloride sodium hydroxide water for injection active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

Israel - Inggeris - Ministry of Health

eli lilly israel ltd - insulin lispro; insulin lispro as protamine - suspension for injection - insulin lispro 25 %; insulin lispro as protamine 75 % - insulin lispro - insulin lispro - humalog mix 25 kwikpen is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

ovelle limited - benzyl benzoate - cutaneous emulsion - 25 percent weight/volume - other ectoparasiticides, incl. scabicides; benzyl benzoate

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

rottapharm ltd - estradiol - transdermal patch - 25 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - fentanyl - transdermal patch - 25 microgram per hour - phenylpiperidine derivatives; fentanyl